ArticleProtein science : a publication of the Protein Society2025
A single residue affects the dynamics and shape of a tetrameric GH43 β-1,4-d-xylosidase from Levilactobacillus brevis DSM1269.
Article in Protein science : a publication of the Protein Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A single residue affects the dynamics and shape of a tetrameric GH43 β-1,4-d-xylosidase from Levilactobacillus brevis DSM1269.Protein science : a publication of the Protein Society · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Lignocellulosic materials (e.g., straw and bran) are gaining interest as feedstocks for the manufacture of higher value products, recognizing xylooligosaccharides (XOS) as interesting prebiotic compounds, and putting enzymes converting xylooligosaccharides into focus. In this work, we are investigating a XOS converting enzyme from the probiotic bacterium Levilactobacillus brevis (formerly Lactobacillus brevis). Growth of multiple L. brevis strains, recognized as probiotics, is promoted by the presence of XOS. This study elucidates the 3D structure of an intracellular L. brevis β-xylosidase, LbXyn43B from glycoside hydrolase family 43 (GH43), resolving it to 1.9 Å resolution. Functional analysis identified LbXyn43B as a mediator for XOS utilization in L. brevis DSM1269. The enzyme, featuring a 5-fold β-propeller fold typical of GH43, prefers short XOS substrates, notably β-1,4-xylobiose and β-1,4-xylotriose, aligning with its role in hydrolyzing internalized XOS. Intriguingly, crystallographic and size exclusion chromatographic evidence reveals LbXyn43B to be a tetramer, contrary to the dimeric structure previously reported in a closely related homolog from strain DSM20054. Despite sharing a high sequence identity (differing in only five residues), Thr274 in LbXyn43B within a subunit interface loop was found to influence the tetramer's shape. When mutated to Ala (the residue at the corresponding position in the homolog), the enzyme's apparent native molecular mass was impacted, resulting in a more compact oligomeric structure of slightly higher thermostability. Kinetic analysis and molecular dynamics simulations further suggest an effect of Thr274Ala substitution in modulating the accessibility of longer oligosaccharides, such as β-1,4-d-xylotetraose, to the active site.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.